Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Amgen

How Is Amgen's Stock Performance Compared to Other Pharmaceuticals Stocks?

Amgen has underperformed the Pharmaceuticals industry over the past year, but analysts are moderately optimistic about the stock’s prospects.

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.

Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.

Investors Business Daily

Stock Market Today: Nasdaq Outperforms as Big Tech Rallies

Stock Market Today: Nasdaq Outperforms as Big Tech Rallies

The Dow Jones Industrial Average closed lower for a second day as Amgen and Merck fell.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

S&P, Dow Pharma Stocks Boomerang On Drug-Pricing Order That Is 'All Bark' And 'Little Bite'

Pharmaceutical stocks boomeranged Monday after Trump signed an executive order tying drug prices in the U.S. to international price tags.

Investors Business Daily

12 Stocks Blow Away Warren Buffett's Long-Term Track Record

Warren Buffett's Berkshire Hathaway sports an enviable long-term track record. But not even Buffett is No. 1 in the S&P 500 in the long run.

Investors Business Daily

Amgen Stock Outlook: Is Wall Street Bullish or Bearish?

Although Amgen has lagged behind the broader market over the past year, Wall Street analysts remain cautiously optimistic about the company’s long-term outlook.

Dow Jones Rallies On Surprise Jobs Report; Apple Dives On Earnings

The Dow Jones rallied Friday on a surprise April jobs report. Apple stock dived on earnings on the stock market today.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

Stocks Soar Before the Open on Upbeat Microsoft and Meta Results, More Big Tech Earnings on Tap

Stocks Soar Before the Open on Upbeat Microsoft and Meta Results, More Big Tech Earnings on Tap

June S&P 500 E-Mini futures (ESM25) are up +1.18%, and June Nasdaq 100 E-Mini futures (NQM25) are up +1.68% this morning as forecast-beating quarterly results from Microsoft and Meta boosted sentiment.

Elon Musk’s retreat from DOGE has lifted Tesla’s valuation by $158 billion—but the stock is still 50% off its peak

Elon Musk’s retreat from DOGE has lifted Tesla’s valuation by $158 billion—but the stock is still 50% off its peak

A TSLA stock rebound led to gains surpassing the current market caps of Amgen or Adobe.

Analysts Think You Should Buy and Hold This 1 Dividend Stock ‘Forever’

Analysts Think You Should Buy and Hold This 1 Dividend Stock ‘Forever’

Amgen stands out as a stable and attractive dividend stock, with a strong lineup of new medicines, a solid 3.45% forward yield, and a 201% dividend growth over the past decade.

Amgen's Quarterly Earnings Preview: What You Need to Know

Amgen's Quarterly Earnings Preview: What You Need to Know

Amgen is scheduled to report its first-quarter results next month, and analysts expect a single-digit earnings growth.

Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan

Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan

Pharma names whipsawed Wednesday after Trump said he would enact "major" tariffs on drug imports and then backed off his tariffs — for now.

Investors Business Daily

Apple And Meta Get Nixed — But Top Funds Binge On This Stock

Apple And Meta Get Nixed — But Top Funds Binge On This Stock

While Megacaps Apple and Meta go AWOL, Netflix stock and insurance firms dominate new buys by the best mutual funds.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Nvidia, Other Techs Hurt Dow Jones, But These Names Outperformed In Q1

Since it joined the Dow industrials on Nov. 7, Nvidia stock is down nearly 30%.

These 2 Buy-Rated Dividend Stocks Could Be Next in Line for a Trump Tariff Selloff. Should You Jump Ship Now?

Trump’s proposed tariffs on pharmaceutical imports from countries like Ireland and India have sparked concerns for companies like Amgen and Gilead Sciences.

The Conversation

With 23andMe filing for bankruptcy, what happens to consumers’ genetic data?

The announcement that 23andMe is filing for bankruptcy and has put its genetic genealogy database up for sale has sent its customers into a bit of a privacy tizzy. On March 21, California Attorney General Bob Bonta issued a consumer alert with detailed instructions about how to delete one’s data.

Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?

Amgen is hoping to rival Novo Nordisk and Eli Lilly in the weight-loss drug market.

Get all your
news in one place.

100’s of premium titles.
One news app.

Amgen Stock: Is AMGN Outperforming the Healthcare Sector?

Amgen has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects.

Investors Business Daily

IBD Rating Upgrades: Amgen Shows Improved Price Strength

A Relative Strength Rating upgrade for Amgen shows improving technical performance. Will it continue?

Investors Business Daily

Stocks Generating Improved Relative Strength: Amgen

Amgen shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Wall Street Predicts This Dividend Stock to Soar 31%: Should You Buy The Dip Now?

Amgen stock is an attractive buy on the dip for passive income-focused investors.

Investors Business Daily

Stock Market Sideways Amid Trump Tariff, Inflation Fears; Palantir, Google, Amazon Among Key Movers: Weekly Review

The stock market was up and down with Trump tariff fears in focus. Palantir led big earnings winners. Google and Amazon were losers.

Earnings Miss? Amgen’s Dividend Still a Bright Spot

AMGN stock is down over 1% despite beating revenue and earnings estimates; investors are selling the news on the company’s latest obesity drug and weak guidance

Investors Business Daily

Dow Jones Falls On Surprise Jobs Data; Google, AMD, Uber Plunge On Earnings

The Dow Jones dropped Wednesday on a strong ADP jobs report. Google, AMD and Uber stock plunged on earnings.

People

119,568 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Executive Order

Dow Jones Industrial Average

Places

276,761 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play